FdaApplication
ANDA 217409
Identifiers
- fda_app_no: ANDA217409
Properties
| Property | Value |
|---|---|
| applicant_name | EUGIA PHARMA SPECIALITIES LTD |
| application_type | ANDA |
| approval_date | 2023-10-12 |
Products (10)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | 3.0G | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | 36G | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | 4.0G | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE;INJECTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | 0.5G/1VIAL | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | EQ 36GM BASE/VIAL | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | 4.5G | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | EQ 12GM BASE/VIAL | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN,TAZOBACTAM | 0.375G | INJECTION;POWDER,FOR SOLUTION |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | INJECTABLE;INJECTION |
10 products